Journal of Digestive Cancer Research

Korean Society of Gastrointestinal Cancer Research (대한소화기암연구학회)
권호 표지

Importance of Quality of Life in Pain Management for Cancer Patients

  • Eun Sun Kim (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Institute of Digestive Disease and Nutrition, Korea University College of Medicine)
  • Received : 2014.04.30
  • Accepted : 2014.05.31
  • Published : 2014.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Patients with uncontrolled pain may become tired, depressed, angry, worried, lonely, and stressed. In contrast, proper management of cancer pain allows patients to be more active, sleep better, enjoy family and friends, improve their appetite, enjoy sexual intimacy, and prevent depression. Pain control is strongly influence to quality of life of cancer patients. This review discusses the importance of quality of life in pain management for cancer patients.

Keywords

References

  1. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 1984;2:187-193.
  2. Celia D, Wagner L, Cashy J, Hensing TA, Yount S, Lilenbaum RC. Should health-related quality of life be measured in cancer symptom management clinical trials? Lessons learned using the functional assessment of cancer therapy. J Natl Cancer Inst Monogr 2007:53-60.
  3. Sloan JA, Celia D, Frost M, Guyatt GH, Sprangers M, Symonds T. Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 2002;77:367-370.
  4. Gatzemeier U, Pluzanska A, Szczesna A, et al. Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-smaU-cell lung cancer: the Tarceva Lung Cancer Investigation Trial. J Clin Oncol 2007;25:1545-1552.
  5. Celia DF. Measuring quality of life in palliative care. Semin Oncol 1995;22:73-81.
  6. Aaronson NK Quality of life: what is it? How should it be measured? Oncology (Williston Park) 1988;2:69-76, 64.
  7. Celia D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years. Med Care 2007;45:S3-S11.
  8. Deandrea S, Montanari M, Moja L, ApoIone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008;19:1985-1991.
  9. Billings JA What is palliative care? J Palliat Med 1998;1:73-81.
  10. Ellison NM. Regulatory issues for prescribing schedule II opioids at the end of life #198. J Palliat Med 2010;13:605-606.
  11. Fishbain DA, Cutler RB, Rosomoff HL, Rosomoff RS. Are opioid-dependent/tolerant patients impaired in driving-related skills? A structured evidence-based review. J Pain Symptom Manage 2003;25:559-577.